Royalty Pharma PLC (RPRX) Social Stream



Royalty Pharma PLC (RPRX): $26.91

0.28 (+1.05%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add RPRX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#61 of 347

in industry

ROYALTY PHARMA PLC (RPRX) Price Targets From Analysts

Use the tables below to see what analysts covering ROYALTY PHARMA PLC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 8 $56.001 $46 $51.714 $28.33 82.54%
2022-02-02 7 $56 $46 $51.714 $28.33 82.54%
2022-03-08 7 $56 $46 $51.142 $28.33 80.52%
2022-04-06 7 $56 $48 $51.428 $28.33 81.53%
2022-05-06 7 $56 $48 $51.428 $28.33 81.53%
2022-06-09 9 $56 $48 $52.111 $28.33 83.94%
2022-06-14 10 $56 $47 $51.6 $28.33 82.14%
2022-08-03 10 $57 $47 $52.3 $28.33 84.61%
2022-10-12 10 $57 $47 $52.6 $28.33 85.67%
2022-10-27 10 $57 $47 $52.8 $28.33 86.37%
2022-11-28 9 $57 $47 $53.111 $28.33 87.47%
2022-12-06 9 $57 $47 $52.777 $28.33 86.29%
2023-02-15 9 $57 $47 $52 $28.33 83.55%
2023-03-29 9 $57 $47 $52.111 $28.33 83.94%
2023-04-10 9 $57 $47 $52.333 $28.33 84.73%
2023-04-21 9 $60 $42 $50.625 $28.33 78.7%
2023-05-10 8 $60 $42 $50.875 $28.33 79.58%
2023-06-06 7 $60 $42 $49.857 $28.33 75.99%
2023-07-11 4 $60 $42 $49.333 $28.33 74.14%
2023-08-08 5 $60 $42 $49.333 $28.33 74.14%
2023-08-09 5 $60 $42 $49.833 $28.33 75.9%
2023-11-08 5 $60 $40 $48.833 $28.33 72.37%
2023-11-10 5 $60 $40 $48.666 $28.33 71.78%
2023-12-12 7 $60 $37 $46.285 $28.33 63.38%

The Trend in the Analyst Price Target


Over the past 30 months, RPRX's average price target has gone down $6.43.

RPRX reports an average of 55.15% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-14 9 57 47 52.333 38.00 37.72%
2023-07-11 5 60 42 49.333 30.71 60.64%
2023-10-02 5 60 40 48.666 26.81 81.52%
2023-11-10 5 60 40 49.428 27.22 81.59%
2023-12-12 6 60 37 46.285 28.51 62.35%

RPRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.21 5 2 0 0 0 7

The Trend in the Broker Recommendations


RPRX's average broker recommendation rating worsened by 0.11 over the prior 35 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RPRX as an investment opportunity.

  • In terms of how ROYALTY PHARMA PLC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 2360.14% of that group.
  • In the context of stocks in the large market cap category, ROYALTY PHARMA PLC's number of analysts covering the stock is greater than 437.57% of them.
  • In terms of how ROYALTY PHARMA PLC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -395.84% of that group.
  • In the context of Pharmaceutical Products stocks, ROYALTY PHARMA PLC's average analyst price target is greater than 2146.66% of them.

Stocks similar to ROYALTY PHARMA PLC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RGNX, HALO, and BCRX.

Is RPRX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!